Skip to main navigation Skip to search Skip to main content

microRNAs as novel antidepressant targets in refractory depression: converging effects of ketamine and electroconvulsive shock therapy

  • Icahn School of Medicine at Mount Sinai

Research output: Contribution to conferenceAbstractpeer-review

Original languageEnglish (Ireland)
Publication statusPublished - 2012

Cite this